Everyone had their concern about 1st dose of vaccine in the USA. Will it be sufficient? Will it work for new variants? Is it completely safe? Will we require a booster in the coming years?
These were the highlights at this week’s meeting of the center for disease control and prevention’s advisory committee on immunization practices (ACIP).
The boosters aren’t the talk of the town yet but the health experts have started looking into the necessity of boosters.
The current vaccine shots are effective against the Coronavirus delta variants. But for some people, the vaccines don’t work mainly on people who are immunocompromised, in particular people who had organ transplants as they are unable to produce antibodies after regular doses of the COVID- 19 vaccine.
According to new research, the third dose of mRNA COVID-19 vaccine can give them more protection.
That’s the group the ACIP seems to think could be the first to get a booster because we have clear signals that it could help them. Then, after we learn more about how long protection lasts for everyone else — or if new variants emerge — experts could hammer out the details about boosters for the rest of us.
There’s no data to support recommendations for booster doses at this time, except for the caveat in severely immunocompromised hosts who are not able to mount a strong response.
Sharon Frey, an ACIP member
But before that, it’s necessary to get fully vaccinated. Only then depending on the conditions the need for boosters can be understood.